ABC00461SQ

Daclatasvir

Daclatasvir comprises a dihydropyrazine core fused to a tetrahydropyridine ring, with a sulfonamide group and aryl ether substitutions. The molecule features a triazole bridge connecting the pyrazine and pyridine moieties, enhancing conformational rigidity. As the parent drug, it retains full pharmacophoric integrity, enabling direct use in analytical workflows. This compound functions as an HPLC reference standard for quantifying antiviral APIs in quality control assays.

On Request
Molecular Formula C40H50N8O6
Molecular Weight 738.9000
CAS Number 1009119-64-5 ✓ Verified
PubChem CID 25154714 ↗
Purity N/A
Product Type API
Parent Drug Daclatasvir
Lead Time On Request
IUPAC Name methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

📝 Synonyms

Daclatasvir 1009119-64-5 BMS-790052 BMS790052 BMS 790052 EBP 883 Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate EBP-883 LI2427F9CI

🔬 Chemical Identifiers

CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1
FKRSSPOQAMALKA-CUPIEXAXSA-N

Related Products